Blueprint Medicines Corp Quarterly Common Stock, Shares, Issued from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Blueprint Medicines Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q2 2024.
  • Blueprint Medicines Corp Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 63.2M shares, a 4.17% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 63.2M +2.53M +4.17% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 62.6M +2.18M +3.61% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 61.1M +1.19M +1.98% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 60.7M +932K +1.56% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 60.6M +950K +1.59% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 60.4M +860K +1.45% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 60M +818K +1.38% Dec 31, 2022 10-K 2024-02-15
Q3 2022 59.8M +994K +1.69% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 59.7M +1.13M +1.94% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 59.6M +1.28M +2.19% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 59.1M +1.35M +2.33% Dec 31, 2021 10-K 2023-02-16
Q3 2021 58.8M +3.3M +5.95% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 58.6M +4.27M +7.87% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 58.3M +4.11M +7.59% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 57.8M +8.52M +17.3% Dec 31, 2020 10-K 2022-02-17
Q3 2020 55.5M +6.34M +12.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 54.3M +5.22M +10.7% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 54.2M +10M +22.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 49.3M +5.24M +11.9% Dec 31, 2019 10-K 2021-02-17
Q3 2019 49.2M +5.23M +11.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 49.1M +5.18M +11.8% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 44.2M +350K +0.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 44M +460K +1.05% Dec 31, 2018 10-K 2020-02-13
Q3 2018 43.9M +4.77M +12.2% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 43.9M +4.8M +12.3% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 43.8M +10.6M +31.8% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 43.6M +10.5M +31.6% Dec 31, 2017 10-K 2019-02-26
Q3 2017 39.2M +11.9M +43.5% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 39.1M +11.8M +43.3% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 33.2M +6.02M +22.1% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 33.1M +5.93M +21.8% Dec 31, 2016 10-K 2018-02-21
Q3 2016 27.3M +212K +0.78% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 27.3M +167K +0.61% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 27.2M +25M +1125% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 27.2M +25M +1126% Dec 31, 2015 10-K 2017-03-09
Q3 2015 27.1M Sep 30, 2015 10-Q 2015-11-09
Q2 2015 27.1M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 2.22M Mar 31, 2015 10-Q 2015-06-11
Q4 2014 2.22M Dec 31, 2014 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.